Tenofovir AlafenamideThird Party Manufacturing in India

Tenofovir Alafenamide works as a phosphonamidate prodrug of tenofovir that penetrates target cells via passive diffusion and specific hepatic transporters. Once intracellular, it is hydrolyzed to tenofovir and subsequently phosphorylated to the active tenofovir diphosphate, which competes with deoxyadenosine 5'-triphosphate for incorporation into viral DNA. It targets viral reverse transcriptase to help the body terminate the viral DNA chain elongation. Unlike tenofovir disoproxil fumarate, it delivers higher intracellular concentrations at a fraction of the dose, minimizing systemic plasma levels. It is highly effective and well-tolerated.

Therapeutic Uses

• Chronic Hepatitis B: Treats chronic HBV infection in adults with compensated liver disease, suppressing viral replication efficiently.
• HIV-1 Infection Antiviral Regimens: Forms a foundational component of combination antiretroviral regimens for managing HIV-1 positive patients.
• Hepatic Health Preservation: Reduces viral load long-term to slow down the progression of cirrhosis and hepatocellular carcinoma.

Why Manufacturers Choose Tenofovir Alafenamide

Tenofovir Alafenamide third party manufacturing in India is a high-value sector within specialized antiviral and chronic infectious disease portfolios. Because it requires low-mg dosing while demanding absolute precision, advanced micro-dose blending validation is critical. Our partner facilities feature dedicated, high-containment production areas that follow strict WHO-GMP guidelines, ensuring zero cross-contamination and providing premium-grade formulations suitable for international tender distributions.